These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26373914)

  • 21. Overuse of Bridging Anticoagulation for Patients With Venous Thromboembolism: First, Do No Harm.
    Brotman DJ; Streiff MB
    JAMA Intern Med; 2015 Jul; 175(7):1169-70. PubMed ID: 26011244
    [No Abstract]   [Full Text] [Related]  

  • 22. Idrabiotaparinux treatment for venous thromboembolism.
    Eikelboom JW; Weitz JI
    Lancet; 2012 Jan; 379(9811):96-8. PubMed ID: 22127297
    [No Abstract]   [Full Text] [Related]  

  • 23. Decreased venous thromboembolism with injectable vs oral anticoagulation after discharge for major orthopedic surgery.
    Kwong LM; Happe LE; Horblyuk R; Farrelly E
    J Arthroplasty; 2008 Sep; 23(6 Suppl 1):25-30. PubMed ID: 18722300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulant therapy for venous thromboembolism.
    Diuguid DL
    N Engl J Med; 1997 Feb; 336(6):433-4. PubMed ID: 9010151
    [No Abstract]   [Full Text] [Related]  

  • 25. D-dimer and duration of anticoagulation.
    Glynn RJ; Goldhaber SZ; Ridker PM
    N Engl J Med; 2007 Jan; 356(4):422-3; author reply 423. PubMed ID: 17256206
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence-Based Therapies for Pharmacologic Prevention and Treatment of Acute Deep Vein Thrombosis and Pulmonary Embolism.
    Jacobs B; Henke PK
    Surg Clin North Am; 2018 Apr; 98(2):239-253. PubMed ID: 29502769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolism.
    Spaulding C
    J Fam Pract; 1995 Dec; 41(6):604-5. PubMed ID: 7500073
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anticoagulation after an acute pulmonary embolism].
    Le Mao R; Tromeur C; Couturaud F
    Presse Med; 2017; 46(7-8 Pt 1):728-738. PubMed ID: 28756076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration of warfarin in pulmonary embolism.
    Miller A; Campbell I; Fennerty T; Raskob GE; Büller HR
    Chest; 2006 Jul; 130(1):299; author reply 299-300. PubMed ID: 16840417
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
    Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
    Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary embolism.
    McRae S
    Aust Fam Physician; 2010 Jul; 39(7):462-6. PubMed ID: 20628658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing.
    Becattini C; Franco L; Agnelli G
    Semin Respir Crit Care Med; 2017 Feb; 38(1):94-106. PubMed ID: 28208203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
    Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of venous thromboembolism.
    Lancet; 1988 Feb; 1(8580):275-7. PubMed ID: 2893086
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of venous thromboembolism.
    Burnett B
    Prim Care; 2013 Mar; 40(1):73-90. PubMed ID: 23402462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent venous thromboembolism: quite harmless after all?
    Konstantinides SV
    Thromb Haemost; 2008 Apr; 99(4):655-6. PubMed ID: 18392321
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther M; White RH; Vickars L; Bazarjani S; Le Gal G
    Thromb Res; 2018 Feb; 162():104-109. PubMed ID: 29224973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
    Büller HR; Gallus AS; Pillion G; Prins MH; Raskob GE;
    Lancet; 2012 Jan; 379(9811):123-9. PubMed ID: 22130488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.